Investors
Newsroom
Careers
- Job Openings

Areas of Focus
Our Medicines
Pipeline
Science & Innovation
Patients & Caregivers
About
- Leadership Team
- Corporate Governance

Investors
Newsroom
Careers
- Job Openings

Woman taking notes in a meeting

Woman taking notes in a meeting

Publications

Now Approved

FDA Approval of Plozasiran to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)

Home /Science & Innovation /

Publications

Filter by

Year Published
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2015
- 2013
- 2012
- 2011
- 2010
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002

Selections

HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell Carcinoma

Read More

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Read More

Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytes

Read More

Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent

Read More

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

Read More

Protease-triggered siRNA delivery vehicles

Read More

Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection

Read More

Co-Injection of a Targeted, Reversibly Masked Endosomolytic Polymer Dramatically Improves the Efficacy of Cholesterol-Conjugated Small Interfering RNAs In Vivo

Read More

Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies

Read More

Myofiber Damage Evaluation by Evans Blue Dye Injection

Read More

2 3 4 5 6...7

Continue to Site

Footer Navigation

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
Careers

Facebook
Instagram
LinkedIn
Twitter

Privacy Policy
Cookie Policy
Terms of Use
Sitemap
Contact Us
Safety Reporting

© 2025 Arrowhead Pharmaceuticals, Inc.